Doxepin (Oral)

Doxepin tablet is indicated for the treatment of insomnia characterized by difficulties with sleep maintenance. 

Doxepin capsule is recommended for the treatment of:

• Psychoneurotic patients with depression and/or anxiety.
• Depression and/or anxiety associated with alcoholism (not to be taken concomitantly with alcohol)
• Depression and/or anxiety associated with organic disease (the possibility of drug interaction should be considered if the patient is receiving other drugs concomitantly).
• Psychotic depressive disorders with associated anxiety including involutional depression a and manic-depressive disorders.

The target symptoms of psychoneurosis that respond particularly well to doxepin include anxiety, tension, depression, s matic symptoms and concerns, sleep disturbances, guilt, lack of energy, fear, apprehension and worry.

Clinical experience has shown that doxepin is safe and well tolerated even in the elderly patient. Owing to lack of clinical experience in the pediatric population, doxepin is not recommended for use in children under 12 years of age.